Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Ayub Med Coll Abbottabad ; 34(Suppl 1)(4): S928-S931, 2022.
Article in English | MEDLINE | ID: covidwho-2280672

ABSTRACT

Background: Evidence on performance of Rapid Antigen Detection Tests to recognize SARS-CoV-2 symptomatic patients in our context is limited. This study was aimed to evaluate Panbio™ COVID-19 Ag Rapid Test Device (Abbott Diagnostics, Jena, Germany) in identifying SARS-CoV-2 infection in comparison with RT-PCR test. Methods: This cross-sectional validation study was carried out at Margalla Hospital, Taxila from October, 2020 to March, 2021. Three hundred and eighty-two participants of both gender and all ages, symptomatic for 3-4 days were included in this study. For each participant, two nasopharyngeal swabs were collected by trained lab technicians according to SOPs, one for Rapid Antigen Test and other for RT-PCR.Covid-19 antibodies were checked 4-6 weeks after symptoms among 77 randomly selected participants to further evaluate the performance of Rapid Antigen Test. Data was analyzed using SPSS-26. Results: The mean age of the participants was 43.1 years (SD=15.9). More than half of participants were males (n=213%=55.8) and 169 (44.2%) were females. Sensitivity of Rapid Antigen Test was calculated to be 94.3%, whereas the specificity was 39.7%. Out of 34 RT-PCR negatives that were initially detected positive on Rapid Antigen Test, 33 demonstrated presence of COVID-19 antibodies. Conclusion: Panbio™ COVID-19 Ag Rapid Test was found to have 93.4% overall sensitivity and relatively low overall specificity (37.9%). Rapid antigen testing using Panbio™ COVID-19 Ag Rapid Test Device can be effectively used to scale up mass testing to interrupt transmissibility of COVID-19 infection by generating quick result.


Subject(s)
COVID-19 , SARS-CoV-2 , Female , Male , Humans , Adult , Infant, Newborn , COVID-19/diagnosis , Cross-Sectional Studies , Reverse Transcriptase Polymerase Chain Reaction , Hospitals , Sensitivity and Specificity
2.
Pakistan Armed Forces Medical Journal ; - (3):801, 2021.
Article in English | ProQuest Central | ID: covidwho-1589790

ABSTRACT

Objective: To determine association of ABO and Rh blood groups with COVID-19 RT-PCR positive status. Study Design: Case control study. Place and Duration of the Study: Department of Pathology, Margalla Hospital Taxila, from Apr 2020 to Dec 2020. Methodology: The sample comprised of 436 cases and 500 controls. Out of 3936 RT-PCR done during the study duration, 436 RT-PCR positives were enrolled in study as cases. 500 age and gender matched controls were selected from same population. Study variables (age, gender, blood groups, RT-PCR result) were obtained from Hospital data (HIMS). Data was analyzed using SPSS version 25. Mean and SD was calculated for age. Frequencies were calculated for categorical variables. p-value calculated applying chi square test. Odds ratios calculated to determine association. Results: The mean age of cases was 37.3 ± 16.3. Statistically significant association was observed between age, gender and COVID-19 RT-PCR positive status. B+ blood group was most frequent both among cases (35.4%) and controls (36.2%), followed by O+ and A+. However, no significant association was observed between blood groups and COVID-19 RT-PCR positivity. Odds ratios calculated for blood group O and non - O (OR=0.95), A antigen (OR=0.97) and Rh factor (OR 0.93) among cases and controls showed week negative association. Whereas a weak positive association of B antigen + and B antigen - with PCR positivity (1.07) was observed between cases and controls. Conclusion: Susceptibility to acquire COVID-19 infection is not associated with ABO and Rh blood groups according to this study.

3.
Pakistan Armed Forces Medical Journal ; (COVID-19 (2))2020.
Article in English | ProQuest Central | ID: covidwho-831002

ABSTRACT

ABSTRACT Objective: To assess the awareness of personal protective equipment usage, among health care providers. Study Design: Cross sectional survey. Place and Duration of Study: Tertiary care hospitals across Pakistan, from 1 st May 2020 to 25 th May 2020 by convenient sampling method. Methodology: A total of 74 responders from different health care setups completed a questionnaire-based survey on the knowledge and practice regarding personal protective equipment usage among healthcare providers. The questionnaire was designed by the help of central disease control (CDC) guidelines and its reliability and validity check by SPSS. Convenient sampling was used for data collection and frequencies and percentages were used to present distribution of responses. WHO sample size calculator (2.2a for population proportions) was used for sample size calculation from previous study 23. Data was tabulated in excel and SPSS 17 was used for Descriptive Statistics. Results: The overall awareness among healthcare providers about personal protective equipment use in COVID-19 was not satisfactory with 40.5% reported correct answers. About 54 (75%) of responders had been in contact with confirmed or suspected COVID-19 patients. Regarding kind of personal protective equipment use, 41 (58.6%) knew the correct sequence of donning as per central disease control guidelines and only 21(30%) knew the correct sequence of doffing. Conclusion: The current survey concluded that although majority of responders had fair knowledge regarding COVID-19, yet many knowledge gaps were there, regarding proper donning and doffing technique of personal protective equipment. Therefore continuous health education and training programs according to the recent guidelines by CDC and WHO, at all health care levels, regarding judicious use of personal protective equipment in COVID-19 is required.

SELECTION OF CITATIONS
SEARCH DETAIL